Companies /Healthcare

Atossa Genetics Inc

NASDAQ: ATOS Biotechnology
$2.53
▲ $0.07 (+2.85%) today
Markets closed · 1:55am ET
Today · % change

Fundamentals

Market Cap
$24.5M
EPS (TTM)
$-4.48
52-Week Range
$2 – $19
Street Target
$18.67

About Atossa Therapeutics

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops drugs in the areas of oncology and infectious diseases. The company is headquartered in Seattle, Washington.

ATOS Coverage